Trump’s pharmaceutical tariffs will dig America deeper into medical debt
By Dr. Lyndon Haviland
July 22, 2025
TheHill.com
President Trump recently announced his intent to impose a 200 percent tariff on pharmaceuticals to lure drug manufacturing back to the U.S. This action, if implemented, will come at great cost to millions of Americans already struggling to cover their medical bills and force them deeper into health care debt. …
It took decades for U.S. pharmaceutical production to move overseas; moving it back to America can’t happen overnight. We need measured policy approaches, not knee-jerk ones, to prevent America’s most vulnerable from digging themselves further in debt to pay for medications many already can’t afford.